|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
EBSCO_ocn832618292 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130327s2012 nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d E7B
|d OCLCF
|d OCLCQ
|d EBLCP
|d DEBSZ
|d OCLCQ
|d D6H
|d OCLCQ
|d VTS
|d TOF
|d AU@
|d STF
|d OCLCQ
|d K6U
|d UKAHL
|d OCLCQ
|d M8D
|d OCLCO
|d OCLCQ
|
| 019 |
|
|
|a 923659860
|a 923661480
|a 924550193
|a 925492743
|
| 020 |
|
|
|a 9781621002055
|q (electronic bk.)
|
| 020 |
|
|
|a 1621002055
|q (electronic bk.)
|
| 029 |
1 |
|
|a DEBBG
|b BV043775265
|
| 029 |
1 |
|
|a DEBSZ
|b 47277722X
|
| 035 |
|
|
|a (OCoLC)832618292
|z (OCoLC)923659860
|z (OCoLC)923661480
|z (OCoLC)924550193
|z (OCoLC)925492743
|
| 050 |
|
4 |
|a RC46
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 38 /
|c Leon V. Berhardt, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science,
|c ©2012.
|
| 300 |
|
|
|a 1 online resource (352 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Medicine and Biology
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 500 |
|
|
|a Title from PDF title page (viewed on March 26, 2013).
|
| 505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 38; ADVANCES IN MEDICINE AND BIOLOGY; ADVANCES IN MEDICINE AND BIOLOGY.; VOLUME 38; Library of Congress Cataloging-in-Publication Data; Contents; Preface; CHAPTER 1. Endogenous Angiogenesis Inhibitors: Is the List Ever Ending?; Abstract; 1. Introduction; 2. Secreted Angiogenesis Inhibitors; 2.1. Parstatin; 2.2. Semaphorin3A; 2.3. Isthmin; 2.4. Ý2-glycoprotein-I (Ý2GPI); 2.5. ADAMTS: A Family of Antiangiogenic Metalloproteinases; 2.5.1. ADAMTS1; 2.5.2. ADAMTS2; 2.5.3. ADAMTS4; 2.5.4. ADAMTS5; 2.5.5. ADAMTS8; 2.5.6. ADAMTS9; 2.5.7. ADAMTS12.
|
| 505 |
8 |
|
|a 3. Cytoplasmic Angiogenesis Inhibitors3.1. Integrin Cytoplasmic Domain Associated Protein-1 (ICAP-1); 3.2. Epithelial Protein Lost In Neoplasm (EPLIN); 3.3. ASK1-Interacting Protein1 (AIP1); 3.4. microRNA; 3.4.1. miRNA-221/222; 3.4.2. miRNA-15 and miRNA-16; 3.4.3. miRNA-21; 3.4.4. miRNA-34a; 3.4.5. miRNA-519c and miRNA-107; 3.4.6. miRNA-179̃2 Cluster; Conclusion; Non-Standard Abbreviations and Acronyms; References; CXHAPTER 2. Angiogenesis, Lymphangiogenesis and Vasculogenic Mimicry in Human Prostate Cancer TherapyJingli; Abstract; Introduction; Prostate Cancer and Angiogenesis.
|
| 505 |
8 |
|
|a Angiogenesis Activators as Therapeutic Targets for Prostate Cancer1. VEGF and VEGFR; 1.1. VEGF in Prostate Cancer Therapy; 1.2. VEGFR in Prostate Cancer Therapy; 2. Integrin ÜvÝ3 in Human Prostate Cancer; Angiostatin and Endostatin in Human Prostate Cancer Angiogenesis; Notch Singalling Pathway and Angiogenesis Paradox in Prostate Cancer; Lymphangiogenesis and Lymph Node Metastasis in Prostate Cancer; Vasculogenic Mimicry and Prostate Cancer; Conclusions and Future Directions; Acknowledgements; Abbreviations; References.
|
| 505 |
8 |
|
|a CHAPTER 3. Structural and Functional Alteration of the Aging Lower Urinary TractAbbreviation; Abstract; Introduction; Epidemiology and Lower Urinary Tract Symptoms in the Elderly; Females; Males; Nocturia; Detrusor Underactivity; Quality of Life; Basic Research on the Structural and Functional Changes of the Aging Bladder; Bladder Contraction and Relaxation; Muscarinic Receptors Changes; Nerve Innervation of the Urinary Bladder; Non-Neuronal Ach Release; Change in Detrusor Contractility; Specific Considerations; Bladder Outlet Obstruction; Diabetes Mellitus; Detrusor Overactivity.
|
| 505 |
8 |
|
|a Detrusor UnderactivityClinical Research on Functional Changes of the Aging Bladder; General Voiding Parameters; Detrusor Overactivity; Detrusor Underactivity with or without Overactivity; Bladder Outlet Obstruction; Nocturia; Clinical Assessment of Elderly Patients with Lower Urinary Tract Dysfunction; Non-Urologic Causes; Drugs that Affect Voiding; Physical Examination and Laboratory Tests; Frequency-Volume Chart, and Post-Void Residual and Uroflowmetry; Urodynamic Evaluation; Management of the Aging Bladder; Life-Style Modification; Bladder Outlet Obstruction.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Clinical medicine.
|
| 650 |
|
0 |
|a Biology.
|
| 650 |
|
2 |
|a Clinical Medicine
|
| 650 |
|
2 |
|a Biology
|
| 650 |
|
6 |
|a Médecine clinique.
|
| 650 |
|
6 |
|a Biologie.
|
| 650 |
|
7 |
|a biology.
|2 aat
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Biology.
|2 fast
|0 (OCoLC)fst00832383
|
| 650 |
|
7 |
|a Clinical medicine.
|2 fast
|0 (OCoLC)fst00864361
|
| 700 |
1 |
|
|a Berhardt, Leon V.
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in medicine & biology. Volume 57.
|d Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012
|z 9781622574384
|w (OCoLC)808498369
|
| 830 |
|
0 |
|a Advances in Medicine and Biology.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535135
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH38280748
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3022034
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10686375
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 535135
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7078150
|
| 994 |
|
|
|a 92
|b IZTAP
|
